The TCC is proud to be attending the 2oth annual THYCA (Thyroid Cancer Survivors’ Association) conference in Baltimore, MD October 6-8, 2017. We are also very excited to be able to help THYCA members get their records into the TCC for safekeeping, better coordination between their doctors, and research. THYCA is reaching out to its […]
Thyroid cancer patients are often required to alter their dietary intake in preparation for either a radioiodine scan and/or treatment. Restricting the amount of iodine in the diet for a period of two weeks does not need to be overly challenging.
A new drug, CUDC-907, that may be able to shrink thyroid tumors that have spread, is now in a phase II trial and being tested in advanced thyroid cancer patients. Currently there are no standard or effective treatment options for aggressive types of thyroid malignancies such as anaplastic and poorly differentiated thyroid cancer. The study […]
A study shows that individuals with indeterminate thyroid nodules may receive an inappropriate initial extent of surgery. The TCC uses the ATA guidelines to automatically provide users with the clinical course suggested by these national guidelines.
A new study has revealed that younger thyroid cancer survivors are at increased risk for certain types of health problems later in life. The TCC aims to educate patients and physicians by providing them with the most up to date research findings.